בשל "הגנת זכויות יוצרים" מובא להלן קישור לתקציר המאמר. לקריאתו בטקסט מלא, אנא פנה/י לספרייה הרפואית הזמינה לך.

Meconium aspiration syndrome (MAS) is a complex respiratory disease that continues to be associated with significant morbidities and mortality.

The pathophysiological mechanisms of MAS include airway obstruction, local and systemic inflammation, surfactant inactivation and persistent pulmonary hypertension of the newborn (PPHN).

Supplemental oxygen and non-invasive respiratory support are the main therapies for many patients. The management of the patients requiring invasive mechanical ventilation could be challenging because of the combination of atelectasis and air trapping.

While studies have explored various ventilatory modalities, evidence to date does not clearly support any singular modality as superior.

Patient’s pathophysiology, symptom severity, and clinician/unit expertise should guide the respiratory management.

Early identification and concomitant management of PPHN is critically important as it contributes significantly to mortality and morbidities.